Omada Health (NASDAQ:OMDA) CAO Sells $26,050.00 in Stock

Omada Health, Inc. (NASDAQ:OMDA) CAO Craig Gracey sold 1,042 shares of the company’s stock in a transaction on Monday, August 10th. The shares were sold at an average price of $25.00, for a total transaction of $26,050.00. Following the completion of the sale, the chief accounting officer directly owned 15,441 shares of the company’s stock, valued at $386,025. This trade represents a 6.32% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink.

Craig Gracey also recently made the following trade(s):

• On Wednesday, July 1st, Craig Gracey sold 637 shares of Omada Health stock. The stock was sold at an average price of $23.00, for a total transaction of $14,651.00.
• On Tuesday, June 30th, Craig Gracey sold 405 shares of Omada Health stock. The stock was sold at an average price of $22.00, for a total transaction of $8,910.00.
• On Monday, June 29th, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $21.00, for a total transaction of $43,743.00.
• On Friday, June 26th, Craig Gracey sold 2,084 shares of Omada Health stock. The shares were sold at an average price of $20.00, for a total transaction of $41,680.00.
• On Wednesday, June 24th, Craig Gracey sold 2,083 shares of Omada Health stock. The shares were sold at an average price of $19.01, for a total value of $39,597.83.
• On Monday, June 22nd, Craig Gracey sold 2,083 shares of Omada Health stock. The stock was sold at an average price of $18.00, for a total value of $37,494.00.
• On Friday, June 12th, Craig Gracey sold 6,894 shares of Omada Health stock. The stock was sold at an average price of $17.42, for a total value of $120,093.48.

Omada Health Trading Down 1.4%

NASDAQ OMDA opened at $24.04 on Friday. Omada Health, Inc. has a 1-year low of $10.28 and a 1-year high of $26.92. The stock has a 50-day moving average of $20.99 and a 200-day moving average of $16.49. The firm has a market cap of $1.47 billion, a PE ratio of 480.80 and a beta of 1.73.

Omada Health (NASDAQ:OMDA) last issued its earnings results on Thursday, August 6th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of ($0.02) by $0.10. Omada Health had a return on equity of 2.60% and a net margin of 1.39%.The company had revenue of $87.83 million during the quarter, compared to analysts’ expectations of $80.93 million. As a group, equities research analysts forecast that Omada Health, Inc. will post -0.01 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Omada Health

Several institutional investors and hedge funds have recently bought and sold shares of the business. Hsbc Holdings PLC purchased a new stake in Omada Health in the 2nd quarter worth approximately $435,000. Canada Pension Plan Investment Board purchased a new position in shares of Omada Health during the second quarter valued at approximately $281,000. Legal & General Group Plc purchased a new position in shares of Omada Health during the second quarter valued at approximately $76,000. The Manufacturers Life Insurance Company bought a new position in shares of Omada Health during the second quarter valued at approximately $215,000. Finally, Bank of Nova Scotia bought a new position in shares of Omada Health during the second quarter valued at approximately $617,000.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the company. Robert W. Baird increased their price objective on Omada Health from $15.00 to $25.00 and gave the company a “neutral” rating in a research note on Wednesday. Morgan Stanley reaffirmed an “overweight” rating and issued a $30.00 target price on shares of Omada Health in a research note on Monday, June 22nd. JPMorgan Chase & Co. upped their price target on shares of Omada Health from $26.00 to $30.00 and gave the company an “overweight” rating in a report on Friday. Evercore reissued an “outperform” rating and set a $20.00 price target on shares of Omada Health in a research report on Friday, May 8th. Finally, Wall Street Zen raised shares of Omada Health from a “hold” rating to a “buy” rating in a report on Saturday, August 8th. Eleven research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $26.50.

Omada Health Company Profile

Omada Health is a digital health company that specializes in the prevention and management of chronic conditions through personalized, technology-driven programs. The company’s platform combines data analytics, behavioral science and human coaching to support individuals at risk for or living with conditions such as prediabetes, type 2 diabetes, hypertension and musculoskeletal disorders. Participants access the program via a mobile app or web portal, where they receive tailored curriculum, feedback on health metrics and ongoing virtual coaching.

In addition to its core disease-management offerings, Omada Health has expanded its services to include mental health support and digital therapeutics for weight management.